Contact

feel free to contact us and we will
get back to you as soon as we can.
  • Head Office
  • Gwanggyo R&D Center
  • USA Office

(34141) BVC #121, 125 Gwahak-ro, Yuseong-
gu, Daejeon, Repulic of Korea

Google map

  • TEL + 82-70-8723-0566
  • FAX + 82-70-7966-0567

info@ztibio.com

(16229) 2F GyeongGi-do Business & Science Accelerator, 107 GwangGyo-ro, YeongTong-gu, SuWon-ci, GyeongGi-do, Republic of Korea

Google map

  • TEL + 82-31-213-0566
  • FAX + 82-31-213-0567

info@ztibio.com

9550 Zionsville Rd Suite 1, Indianapolis, IN 46268, United States

Google map

info@ztibio.com

Standard Radiopharmaceuticals
for Theragnostic Oncology

About us

About us

Zero To 1(one), ZTI stands for developing new technologies that were never before.

ZTI BIOSCIENCES, combining its very own original platform nanotechnology with biotech, is developing a next generation therapeutic radiopharmaceuticals for intractable & recurring solid cancers.
ZTI, with the Nano Platform tech TERACARRIERTM, will bring a new paradigm of cancer care, unearthing the full potential of radioisotopes, standardizing radiopharmaceuticals, and providing innovative solutions for various indications in the area of intractable oncology.

Business Model

Business Model

History

Partners Our Team History